key: cord-0291663-2bdeohnj
authors: Chiasson, Melissa A.; Rollins, Nathan J.; Stephany, Jason J.; Sitko, Katherine A.; Matreyek, Kenneth A.; Verby, Marta; Sun, Song; Roth, Frederick P.; DeSloover, Daniel; Marks, Debora; Rettie, Allan E.; Fowler, Douglas M.
title: Multiplexed measurement of variant abundance and activity reveals VKOR topology, active site and human variant impact
date: 2020-05-10
journal: bioRxiv
DOI: 10.1101/2020.05.10.087312
sha: 8b57fc3ac845efbf9ad5a53b8beaf7ded82e2059
doc_id: 291663
cord_uid: 2bdeohnj

Vitamin K epoxide reductase (VKOR) drives the vitamin K cycle, activating vitamin K-dependent blood clotting factors. VKOR is also the target of the widely used anticoagulant drug, warfarin Despite VKOR’s pivotal role in coagulation, its structure and active site remain poorly understood. In addition, VKOR variants can cause vitamin K-dependent clotting factor deficiency 2 or alter warfarin response. Here, we used multiplexed, sequencing-based assays to measure the effects of 2,695 VKOR missense variants on abundance and 697 variants on activity in cultured human cells. The large-scale functional data, along with an evolutionary coupling analysis, supports a four transmembrane domain topology, with variants in transmembrane domains exhibiting strongly deleterious effects on abundance and activity. Functionally constrained regions of the protein define the active site, and we find that, of four conserved cysteines putatively critical for function, only three are absolutely required. Finally, 25% of human VKOR missense variants show reduced abundance or activity, possibly conferring warfarin sensitivity or causing disease.

warfarin response. Here, we used multiplexed, sequencing-based assays to measure the effects 23 of 2,695 VKOR missense variants on abundance and 697 variants on activity in cultured human 24 cells. The large-scale functional data, along with an evolutionary coupling analysis, supports a 25 four transmembrane domain topology, with variants in transmembrane domains exhibiting 26 strongly deleterious effects on abundance and activity. Functionally constrained regions of the 27 protein define the active site, and we find that, of four conserved cysteines putatively critical for 28 function, only three are absolutely required. Finally, 25% of human VKOR missense variants show 29 reduced abundance or activity, possibly conferring warfarin sensitivity or causing disease. 30

The enzyme vitamin K epoxide reductase (VKOR) drives the vitamin K cycle, which 32 activates blood coagulation factors. VKOR, an endoplasmic reticulum (ER) localized 33 transmembrane protein encoded by the gene VKORC1, reduces vitamin K quinone and vitamin 34 K epoxide to vitamin K hydroquinone (Li et al., 2004; Rost et al., 2004) . Vitamin K hydroquinone 35 is required to enable gamma-glutamyl carboxylase (GGCX) to carboxylate Gla domains on 36 Topology informs basic aspects of VKOR function including where vitamin K and warfarin 51 bind, so determining the correct topology and validating the homology model is critical. In 52 particular, VKOR has four functionally important, absolutely conserved cysteines at positions 43, 53 51, 132, and 135, the orientation of which differs between the two proposed topologies. In the 54 four transmembrane domain topology, all four cysteines are located on the ER lumenal side of 55 the enzyme. In this topology, cysteines 43 and 51 are hypothesized to be "loop cysteines" that 56 line, n = 2,695). The missense variant density is colored as a gradient between the lowest 10% 132 of abundance scores (blue), the WT abundance score (white) and abundance scores above WT 133 (red). d, Heatmap showing abundance scores for each substitution at every position within VKOR. 134

Heatmap color indicates abundance scores scaled as a gradient between the lowest 10% of 135 abundance scores (blue), the WT abundance score (white), and abundance scores above WT 136 (red). Grey bars indicate missing variants. Black dots indicate WT amino acids. e, Number of 137 substitutions scored at each position for abundance. f, Scatterplot comparing VAMP-seq derived 138 abundance scores to mean eGFP:mCherry (n = 1 replicate) ratios measured individually by flow 139 cytometry. Variants were selected at random to span the abundance score range. 140 We also measured VKOR variant activity, adapting a HEK293 cell assay based on vitamin 146 K-dependent gamma-glutamyl carboxylation of a cell-surface reporter protein (Haque et al., 147 2014) . In this assay, if VKOR is active, a Factor IX domain reporter is carboxylated, secreted and 148 retained on the cell surface where it is detected with a carboxylation-specific, fluorophore-labeled 149 antibody. However, if VKOR is inactive, the reporter is not carboxylated and the antibody cannot 150 bind (Fig. 2a) . We modified the HEK293 activity reporter cell line to eliminate endogenous VKOR 151 activity by knocking out both VKORC1 and its paralog, VKORC1-like 1 (VKORC1L1) ( Recombination of WT VKORC1 into the landing pad of the HEK293 VKOR activity reporter cell 155 line yielded robust reporter activation, demonstrating that the reporter line could be used to assess 156 the activity of a library of VKOR variants (Fig. 2b) . 157

We recombined a library of VKORC1 variants into the HEK293 activity reporter cell line, 158 and sorted recombinant cells into quartile bins based on carboxylation-specific antibody binding. 159

Each bin was deeply sequenced and, as for VAMP-seq, an activity score was computed for each 160 variant. Final activity scores and confidence intervals were computed from six replicates for a total 161 of 697 missense variants, 21.5% of those possible ( 2010). We found four clearly demarcated regions where charged substitutions profoundly reduced 187 VKOR abundance, relative to aliphatic substitutions (Fig. 3b) . To exclude the possibility that the 188 eGFP tag used in our VAMP-seq assay somehow affected topology, we also analyzed the activity 189 score data. The activity data, derived using native, untagged VKOR, revealed the same four 190 minima as the abundance data (Fig. 3c ). In addition to these four minima, we also observed an 191 activity score minimum at position 57, corresponding to a conserved serine at this position. This 192 serine occurs at the end of the lumenal half-helix hypothesized to shield the active site from non-193 specific oxidation, so it is likely this signal is the result of disruption of that half helix. Together, 194 these results strongly support the hypothesis that, like its distant bacterial homolog, human VKOR 195 has four transmembrane domains. 196

To validate these findings, we performed evolutionary coupling analysis to infer the three-197 dimensional structure suggested by co-evolution. We aligned 2,770 VKOR sequences from both 198 eukaryotes and prokaryotes and identified coupled residues using the EVcouplings software 199 We identified non-local evolutionary coupling patterns characteristic of three-dimensional 205 contacts, which also strongly supported the four transmembrane domain model. Using these 206 13 contacts, we computationally folded human VKOR, yielding a modeled structure similar to the 207 bacterial structure (RMSD = 2.58 ÅA over 97/143 Calpha, Figure 3 -figure supplement 1). The 208 predicted tertiary structure hasd a four-helix topology, with antiparallel contacts between 209 transmembrane domains 1 and 2 (Fig. 3e, Fig. 3f ) and between transmembrane domains 1 and 210 4 (Fig. 3e, Fig. 3g with columns showing median abundance score, median activity score, rescaled scores, and 377 specific activity score. 378

Variation in VKOR is linked to both disease and warfarin response, but the overwhelming 380 majority of VKOR variants found in humans so far have unknown effects. Thus, we curated a total 381 of 215 variants that had either been previously reported in the literature as affecting warfarin 382 response (Supplementary Table 3 Table 4 ). All synonymous variants with the exception of two were WT-like or 393 possibly WT-like, while the three nonsense variants scored had as having low abundance (Fig.  394 6a). Missense variants spanned all abundance categories, with 129 (60%) having WT-like or 395 possibly WT-like abundance. 30 missense variants were low abundance, and 12 were high 396 abundance. The single known pathogenic variant R98W was low abundance (Fig. 6b) . We also 397 classified 54 variants according to their activity (Supplementary Table 4 , but it is unclear whether these variants have appreciable effects 405 on abundance or activity. We found that warfarin resistance variants span a range of abundances 406 and that the distribution of warfarin resistant variant abundance was not different from missense 407 variants generally (Fig. 6c , two-sided Kolmogorov-Smirnov test p= 0.438). Five warfarin-408 resistance variants had low abundance, suggesting that these variants must block drug binding 409 or increase activity to confer resistance. One variant, A26T, had high abundance, a possible 410 mechanism of warfarin resistance. The five warfarin resistance variants, R58G, W59L, V66M, 411 G71A, and N77S, whose activity we scored, were all WT-like. Thus, our abundance and activity 412 data are consistent with warfarin resistance arising largely from variants that block warfarin We conducted multiplexed assays to measure the effects of 2,695 VKOR variants on 425 abundance and 697 variants on activity. Both abundance and activity data provided evidence for 426 a four transmembrane topology, which was further supported by evolutionary couplings analysis. 427

We evaluated a VKOR homology model in the context of the patterns of variant effects on 428 abundance we measured, and found that the homology model could explain these patterns. Low positions (V112, S113). In light of the fact that substitutions at F87 and Y88 resulted in low 435 abundance, we note that the modeled vitamin K binding mode would disrupt packing of VKOR 436 core residues and require repacking of helices to maintain protein stability (Merkle et al., 2018) . 437

In addition to the active site, substitutions at the dilysine and, to a lesser extent, the diarginine ER 438 localization motifs caused abundance loss. 439

We also used our large-scale functional data to analyze 215 VKOR variants found in 440 humans. 16% of these variants affect neither activity nor abundance; we identified 54 previously 441 uncharacterized low abundance or low activity variants that could be pathogenic or alter warfarin 442 response. We found that only one warfarin resistance variant had increased abundance, 443

indicating that increased abundance is not a pervasive warfarin resistance mechanism. All five of 444 the warfarin resistance variants whose activity we scored were WT-like. Taken together these 445 data support the notion that warfarin resistance generally involves alterations to warfarin binding 446 rather than abundance or activity. We analyzed one known warfarin sensitivity variant, W5X, and 447 found that it is low abundance, suggesting that one should not exclude the possibility that any of 448 the 52 other low abundance variants, if found in a person, also confer warfarin sensitivity. 449 29 While our VKOR variant abundance and activity data illuminates various aspects of 450 VKOR's structure and function, the data have limitations. For example, neither assay captures 451 variant effects on mRNA splicing. Both assays have limited dynamic ranges, meaning that subtle 452 effects on abundance or activity cannot be discerned. In addition, both assays have inherent 453 noise, largely arising from the limited number of cells we can sample due to the bottleneck of cell 454 sorting. We account for this noise by filtering each dataset based on variant frequency and 455 presenting a confidence interval for each abundance and activity score. 456

In the future, we envision that the assays we used could be employed to better understand 457 VKOR's interaction with warfarin. Here, we could measure warfarin's effect on both variant 458 abundance and activity, mapping the warfarin binding site more finely. In addition, we could 459 identify warfarin resistance mutations that have not yet been observed in the clinic and group 460 variants by their putative resistance mechanism. Overall, our work highlights the value of 461 scores scaled as a gradient between the lowest 10% of activity scores (blue), the WT activity 524 score (white) and activity scores above WT (red). Grey indicates missing data. b, Heatmap of 525 abundance scores for cysteines. Catalytic cysteines C132 and C135 labeled in green. Color 526 legend same as described in a, applied to abundance scores. 527 (Oldenburg et al., 2004) 26 A26T (Watzka et al., 2011) 26 A26P (Bodin et al., 2008) 27 L27V (Peoc'h et al., 2009) 28 H28Q (Watzka et al., 2011) 29 V29L (Oldenburg et al., 2004) 34 A34P (Harrington et al., 2011) 36 D36Y (Loebstein et al., 2007) 36 D36G (Watzka et al., 2011) 41 A41S (Rieder et al., 2005) 45 V45A (Oldenburg et al., 2004) 52 S52W 66 V66G (Watzka et al., 2011) 68 H68Y (Osman et al., 2006) 71 G71A (Watzka et al., 2011) 77 N77Y (Watzka et al., 2011) 77 N77S (Watzka et al., 2011) 123 I123N (Watzka et al., 2011) 128 L128R (Oldenburg et al., 2004) 139 Y139H 

General reagents, DNA oligonucleotides, and plasmids. 560

Details on general reagents can be found in Supplementary Table 5. Unless otherwise  561 noted, all chemicals were obtained from Sigma and all enzymes were obtained from New 562 England Biolabs. E. coli were cultured at 37°C in Luria broth. All cell culture reagents were 563 purchased from ThermoFisher Scientific unless otherwise noted. HEK 293T cells (ATCC CRL-564 3216) and derivatives thereof were cultured in Dulbecco's modified Eagle's medium 565 supplemented with 10% fetal bovine serum, 100 U ml -1 penicillin, and 0.1 mg ml -1 streptomycin. 566

Cells were induced with 2.5 ug mL -1 doxycycline. Cells were passaged by detachment with 567 trypsin-EDTA 0.25%, and cells were prepared for sorting by detachment with versene. All cell 568 lines tested negative for mycoplasma. Because our activity assay is vitamin-K dependent, all 569 activity assays were done with the same lot of FBS to ensure similar concentrations of vitamin K 570 in each replicate. 571

All synthetic oligonucleotides were obtained from IDT and can be found in 572

Supplementary 

A gBLOCK with a codon-optimized sequence for human VKOR was ordered from IDT. It 577 was then cloned into the vector pHSG298 (Clontech). Saturation mutagenesis primers were 578 designed for each codon in VKOR from positions 2 to 163(Jain and Varadarajan, 2014) and 579 ordered resuspended from IDT. Forward and reverse primers for each position were mixed at 2.5 580 mM, and used in a PCR reaction with 125 pg of pHSG298-VKOR, 5% DMSO, and 5 uL of KAPA 581

Hifi Hotstart 2X ReadyMix. PCR products were visualized on a 0.7% agarose gel to confirm 582 amplification of the correct product. 583 584 49 PCR products were then quantified using the Quant-iT PicoGreen dsDNA Assay kit 585 (Invitrogen) using DNA control curves done in triplicate.

To pool, a total amount of DNA for 586 each reaction was calculated that maximized the volume to be drawn from the lowest 587 concentration PCR product. Pooled PCR products were cleaned and concentrated using 588

Zymogen Clean and Concentrate kit and then gel extracted. The pooled library was 589 phosphorylated with T4 PNK (NEB), incubated at 37°C for 30 minutes, 65°C for 20 minutes, and 590 then 4° indefinitely. 8.5 uL of this phosphorylated product was combined with 1 uL of 10X T4 591 ligase buffer (NEB) and 0.5 uL of T4 DNA ligase (NEB) to make a 10 uL overnight ligation reaction. 592

This reaction was incubated at 16°C overnight. 593

The overnight ligation was then cleaned and concentrated (Zymogen) and eluted in 6 uL 594 of ddH2O. 1 uL of this ligation was then transformed into high efficiency E. coli using 595 electroporation at 2 kV. Each reaction contained 1 uL of ligation (or ligation control or pUC19 10 596 pg/uL) and 25 uL of E. coli. 975 uL of pre-warmed SOC media was added to each cuvette after 597 electroporation, transferred to a culture tube, and recovered at 37°C, shaking for 1 hour. At 1 598 hour, 1 and 10 uL samples from all cultures were taken and plated on appropriate media (LB + 599 kanamycin for ligation and ligation control; LB + ampicillin for pUC19), the remaining 989 uL was 600 used to inoculate a 50 mL culture (+ kanamycin). Plates and 50 mL culture were incubated at 601 37°C overnight (shaking for 50 mL culture). Colonies on plates were then counted, and counts 602 were used to calculate how many unique molecules were transformed to gauge coverage of the 603 library. 50 mL culture was spun down and midiprepped. 604

To transfer the library from pKan to the recombination vector, the pKan library and 605 recombination vector were digested with XbaI and AflII for 1 hour at 65°C. The library and cut 606 vector were then gel extracted. The library was then ligated with the cut vector at 5:1 using T4 607 ligase, overnight at 16°C. The ligation was heat inactivated the next morning, clean and 608 concentrated. Another high efficiency transformation was performed the same as described 609 above, except this ligation was plated on LB + ampicillin (antibiotic switching strategy). Plates and 610 50 50 mL culture were incubated at 37°C overnight (shaking for 50 mL culture). Colonies on plates 611 were then counted, and counts were used to calculate how many unique molecules had been 612 transformed to gauge coverage of the library. A 50 mL culture was spun down and midiprepped. 613

To barcode individual variants, plasmid library harvested from midiprep was digested with 614

EcoRI-HF and NdeI at 37°C for 1 hour, 65°C for 20 minutes. Barcode oligos were ordered from 615 IDT, resuspended at 100 uM, and then annealed by combining 1 uL each of primer with 4 uL 616 CutSmart Buffer and 34 uL ddH2O and running at 98°C for 3 minutes followed by ramping down 617 to 25°C at -0.1°C/second. After annealing, 0.8 uL of Klenow polymerase (exonuclease negative, 618 NEB) and 1.35 uL of 1 mM dNTPS was then combined with the 40 uL of product to fill in the 619 barcode oligo (cycling conditions: 25°C for 15:00, 70°C for 20:00, ramp down to 37°C at -0.1°C/s). 620

Digested vector and barcode oligo were then ligated overnight at 16°C. 621

The overnight ligation was then cleaned and concentrated and eluted in 6 uL of ddH2O. 1 622 uL of this ligation was then transformed into high efficiency E. coli using electroporation at 2 kV. 623

Each reaction contained 1 uL of ligation (or ligation control or pUC19 10 pg/uL) and 25 uL of E. 624 coli. 975 uL of pre-warmed SOC media was added to each cuvette after electroporation, 625 transferred to a culture tube, and recovered at 37°C, shaking for 1 hour. At 1 hour, 1 and 10 uL 626 samples from water and pUC19 cultures were taken and plated on LB supplemented with 627 ampicillin. For ligation and ligation control, four flasks were prepared with 50 mLs of LB and 628 ampicillin, and then 500 uL, 250 uL, 125 uL, 62.5 uL was sample from the 1 mL of recovery and 629 transferred into a corresponding flask. From those flasks, 1 uL, 10 uL, and 100 uL, were sampled 630 and plated onto LB ampicillin plates. Plates and 50 mL culture were incubated at 37°C overnight. 631

Colonies on plates were then counted, and counts were used to calculate how many unique 632 molecules were transformed to gauge number of barcodes. Flask with the target number of 633 barcodes was then spun down and midiprepped. 634 635 Cell line description 636

Altered Escherichia coli membrane protein assembly machinery allows proper 938 membrane assembly of eukaryotic protein vitamin K epoxide reductase

Molecular code for transmembrane-helix recognition by the Sec61 942 translocon

Protein 944 targeting and degradation are coupled for elimination of mislocalized proteins

The EVcouplings Python framework for coevolutionary sequence 952 analysis

A rapid, efficient, and economical inverse polymerase chain 954 reaction-based method for generating a site saturation mutant library

Dictionary of protein secondary structure: pattern recognition of 957 hydrogen-bonded and geometrical features

The Genome Aggregation Database Consortium

Variation across 141,456 human exomes and 969 genomes reveals the spectrum of loss-of-function intolerance across human protein-coding 970 genes

Effect of the VKORC1 D36Y variant on warfarin dose requirement and 973 pharmacogenetic dose prediction

ClinVar: public archive of relationships among sequence variation and human phenotype

Identification of the gene for 979 vitamin K epoxide reductase

Structures of an intramembrane vitamin 981

K epoxide reductase homolog reveal control mechanisms for electron transfer

Structure of a bacterial 984 homologue of vitamin K epoxide reductase

A coding VKORC1 Asp36Tyr polymorphism 987

predisposes to warfarin resistance

Protein 990 3D structure computed from evolutionary sequence variation

Multiplex assessment of protein variant abundance by massively parallel 995 sequencing

A platform for functional assessment of large 997 variant libraries in mammalian cells

Rules for the recognition of dilysine retrieval motifs by coatomer

Substrate-modulated unwinding of transmembrane helices in the NSS transporter LeuT

Packing of apolar 1004 side chains enables accurate design of highly stable membrane proteins

Fine-tuning the topology of a polytopic membrane protein: role of 1007 positively and negatively charged amino acids

Mutations in the VKORC1 Gene Cause 1011

Warfarin Sensitivity and Combined Deficiency of Vitamin K 1012

An algorithm for managing 1014 warfarin resistance

Main haplotypes and 1016 mutational analysis of vitamin K epoxide reductase (VKORC1) in a Swedish population: a 1017 retrospective analysis of case records

VKORC1 Pharmacogenomics

A new VKORC1 mutation 1022 leading to an isolated resistance to fluindione

Effect of VKORC1 Haplotypes on Transcriptional Regulation 1026 and Warfarin Dose

Novel Insight into the Mechanism 1028 of the Vitamin K Oxidoreductase (VKOR) ELECTRON RELAY THROUGH Cys43 AND 1029

Mutations in 1034 VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2

A 1037 statistical framework for analyzing deep mutational scanning data

VKORC1 mutations in patients with partial resistance to 1041 phenprocoumon

Vitamin K epoxide reductase prefers ER 1043 membrane-anchored thioredoxin-like redox partners

A comprehensive comparison of transmembrane 1046 domains reveals organelle-specific properties

Warfarin traps human vitamin K epoxide reductase in an 1050 intermediate state during electron transfer

Human Vitamin K Epoxide Reductase and Its Bacterial 1053

Homologue Have Different Membrane Topologies and Reaction Mechanisms

Evaluation of warfarin resistance using transcription 1056 activator-like effector nucleases-mediated vitamin K epoxide reductase knockout HEK293 1057 cells

Structured States of Disordered Proteins from Genomic Sequences

A series 1062 of PDB-related databanks for everyday needs

Amino acid distributions in integral membrane protein 1065 structures

Control of topology and mode of assembly of a polytopic membrane protein 1067 by positively charged residues

Thirteen novel VKORC1 mutations associated with oral anticoagulant 1070 resistance: insights into improved patient diagnosis and treatment

A new VKORC1 allelic 1073 variant (p.Trp59Arg) in a patient with partial resistance to acenocoumarol and 1074 phenprocoumon

Warfarin and vitamin K 1076 epoxide reductase: a molecular accounting for observed inhibition

The I-TASSER Suite: protein structure 1079 and function prediction

A novel functional VKORC1 promoter polymorphism is 1082 associated with inter-individual and inter-ethnic differences in warfarin sensitivity

Biochemical basis of hereditary resistance to warfarin in 1085 the rat

HEK293T cells with a serine integrase landing pad integrated at the AAVS1 locus were 638 used (Matreyek et al., 2017) . Disruption of VKORC1 and VKORC1L1 was confirmed by performing nested PCR, TA cloning, 653 and then sequencing of products. We detected three alleles for both VKORC1 and VKORC1L1, 654indicating that these loci are triploid in HEK293 cells. 655A Western blot was also used to confirm absence of VKOR protein product in our activity 656 reporter cell line. Protein lysates were harvested from ~1 million cells using 100 uL NP40 lysis 657 buffer with freshly prepared protease inhibitor cocktail and 1 mM PMSF. Protein lysates were 658Qubited for concentration, and 20 ug of each protein lysate was loaded. 4-12% BisTris NuPage 659 gel (Thermo Fisher) was used with MES buffer + 500µl of antioxidant added to the inner chamber. 660The gel ran at 150V for 90 min. Gel was then transferred to Nitrocellulose using 1X transfer buffer 661 20% EtOH at 24V for 1 hour on ice. The blot was washed for 5 minutes with 1X TBS-T 0.1% 662 52 Tween 3 times. Blot was then blocked for overnight 1X TBS-T 0.1% Tween + 5% Milk. Blot was 663 then washed for 5 minutes with 1X TBS-T 0.1% Tween 3 times. Blot was then cut in half at the 664 between the 25kDa and 35kDa molecular weight markers. The bottom blot was incubated with: 665 αVKOR 1:1000 + 1X TBS-T 0.1% Tween + 5% Milk. The top blot was incubated with αbeta-actin 666 dHRP 1:1000+ 1X TBS-T 0.1% Tween + 5% Milk. Both blots were incubated with their primary 667 antibodies overnight at 4ºC. The αVKOR blot was washed for 5 minutes with 1X TBS-T 0.1% 668 Tween 3 times. The αVKOR blot was then incubated with 1:10,000 secondary anti-mouse-HRP 669 (GE Healthcare NA931V) + 1X TBS-T 0.1% Tween + 5% Milk for one hour. The αbeta-actin dHRP 670 blot remained in primary antibody during this time, as no secondary antibody is needed for a direct 671 HRP conjugate. Both blots were then washed for 5 minutes with 1X TBS-T 0.1% Tween 3 times. 672Blots were then incubated with Supersignal West Dura Extended Duration Substrate (Thermo 673 Fisher). 500µl of both substrates incubated on blot for 5 min. Blots were then dried by kimwipe 674 and exposed using the colorimetric and chemiluminescence functions on the BioRad ChemiDoc 675 MP (Biorad). Recombined cells were run on a BD Aria III FACS machine. Cells were prepared for 711 sorting as described above, and were then gated for live, recombined singlets. A ratio of 712 eGFP/mCherry was created using the BD Diva software as a unique parameter, and the 713 histogram of this ratio was divided into four equal bins. Each quartile was sorted into a 5 mL tube 714 54 on "4-Way Purity" mode. Sorted cells were grown out for 2-4 days post sorting to ensure enough 715 DNA for sequencing. The details of replicate sorts for activity assay are in Supplementary Table  716 1. 717 718

Factor IX Gla domain antibody specific for carboxylation was conjugated to APC following 720 that low frequency variants introduced noise to the analysis. These frequencies were then each 791 57 weighted by multiplying by 0.25, 0.5, 0.75, and 1 in a bin-wise fashion. We generated a replicate 792 score for each variant by using min-max normalization: normalizing to the median weighted 793 average of the nonsense distribution set at 0 and the median weighted average of the 794 synonymous distribution set at 1. We then averaged those scores for a final, experiment-wide 795 variant score. Standard deviation and standard error were also calculated for each variant, and 796 95% confidence intervals were estimated using standard error, assuming a normal distribution. 797Abundance and activity classifications were assigned by assessing variant score and confidence 798 intervals in relation to synonymous variant distribution. To do this, we established a cut-off that 799 separated the 5% of synonymous variants with the lowest abundance (or activity) scores from the 800 95% of synonymous variants with higher abundance (or activity) scores. Variants with both scores 801 and upper confidence intervals below this threshold were classified as "low," while those with 802 scores below but upper confidence above were classified as "possibly low." Variants with scores 803 and lower confidence intervals above the threshold were classified as "WT-like", while those with 804 scores above lower confidence intervals below the threshold were classified as "possibly WT-805 like." Finally, another threshold was set that separated the 5% of synonymous variants with the 806 highest scores from the rest of the synonymous distribution. Variants that had scores above this 807 threshold, with lower confidence intervals above the lower threshold were classified as "high. EVcouplings extracts the constraints between pairs of residues, as evidenced in 816 alignments of homologous sequences: first homologous sequences must be collected and 817 58 aligned, and then a model of statistical energy costs and benefits between residues is fit to explain 818 the sequence variation in the alignment. We collected an alignment of 2770 sequences using 819 jackhammer (http://hmmer.org/) to query the human VKOR sequence against UniRef100 820 (https://www.uniprot.org/uniref/), with a bitscore per residue cutoffs of 0.4 and 7 search iterations. 821We predicted secondary structures where the summed strength of couplings at would-be alpha 822 helix and beta strand contacts scored above 1.5 for alpha helices and 0.75 respectively, for two 823 or more consecutive residues. We extended the called helices and strands by one residue on 824 each side for a minimum structure size of four residues. All methods used for building alignments, Activity and abundance scores were rescaled so that the lowest score present in the 840 dataset was set at 0, and the highest score at 1. A ratio of rescaled activity to rescaled abundance 841 (specific activity) was then calculated for every variant. Using variant specific activity scores, 842 median specific activity was calculated for each position. Threshold for classification as an active 843 59 site position was drawn based on scores of known redox cysteines at positions 132 and 135, 844 resulting in lowest 12.5% of median specific activity scores being classified as active site residues. 845We additionally required that any position within this group had been scored for at least four 846 variants to eliminate noise from poor sampling.